Steinbeißer Project Management
Some news ...
I was organising the workshop of the project PREFER. The workshop was about methods to elicitate patient preferences and took place in the premises of Bayer in Berlin. More than 70 attendees from Europe and the US attended the workshop in person or remotely. Thank you all for your participation, it is so great working with you!
The Innovative Medicines Initiative (IMI) is turning 10 today. I have worked the last 7.5 years on IMI projects and I have to say it is an exciting journey watching industry and public partners collaborate. Keep on going IMI projects!
We are looking for a working student to help us with grant applications. If you are interested to learn how modern research proposals are written please contact us with your short CV. Please find more information on the open position here: Career
BigData@Heart: Big Data for Better Hearts
13 September, 2017 - 14:00 - 15:00 CEST
This webinar will introduce and outline the objective of the BigData@Heart project: develop a data-driven translational research platform of unparalleled scale and phenotypical resolution, with the aim to improve patient outcomes and reduce societal burden of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS). Register
Professor of Clinical Epidemiology
University Medical Center Utrecht
Consultant Cardiologist, Professor of Cardiovascular Genetics
University Medical Center Utrecht
Scientific Coordinator of BigData@Heart
ESC Past President
European Heart Agency
Chief Startegy Officer (Brussels)
Director of Edpidemiology
Vital Transformation (moderator)
It's my pleasure to introduce you to my working place. My office is located in WERK1 which in the midst of the most vibrant area of Munich - the Werksviertel. Full of startups, digital entrepreneurs and artists. The campus is subsidised by the Bavarian Ministry of Economic Affairs and provides facilities and environment that support us founders and innovators to grow and succeed with our ideas.
The annual meeting of the PREFER project will be convened on October 26-27th 2017 at Actelion in Allschwil near Basel, Switzerland. We are organising this project meeting and we look forward presenting and discussing the project’s progress with members of the consortium and invited stakeholders.
We are involved in our second heavyweight 19 million public-private partnership project running for 5 years: BigData@Heart.
The objective of the project is to develop a data-driven translational research platform of unparalleled scale and phenotypical resolution, with the aim to improve patient outcomes and reduce societal burden of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS).
For more info: www.bigdata-heart.eu
Giving patients a voice in drug development - PREFER is a five year project funded by the Innovative Medicines Initiative (IMI), to evaluate different preference elicitation methods and test them in a clinical setting.
16 pharmaceutical companies and 16 public partners form the project consortium with a total budget of 12 million €.
For more info: www.imi-prefer.eu
We love what we do and we strongly believe that European funded research has an impact. Unfortunately there is still a lot of administrative burden for researchers. During setting up a special project such as a European funded collaboration many do reinvent the wheel again. We want to be part of a global solution minimizing the burden not only for our clients. Therefore we will share our best practice templates under a free licence to increase the efficiency of research.